ORGOSMALL

Organogenesis Holdings Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$2.56
$0.00(-1.16%)
52W$2.21
$7.08
Updated May 7, 12:00 AM
RSI56
RS Rating9/99
Beta1.92
Volatility88%
F-Score3/9
Mkt Cap$325M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

Organogenesis Holdings Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 9), showing significant lag compared to the market leaders. Earnings growth of 6% provides fundamental context to the price action. Investors should exercise caution due to high volatility (88% annualized), which requires wider risk management.

Relative Strength
9
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
1.92
vs S&P 500
HIGH BETA
52W Position
7%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.57
50 SMA > 100 SMA$3.46
100 SMA > 150 SMA$3.88
150 SMA > 200 SMA$4.09

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.45+4.60%ABOVE
50 SMA$2.57-0.20%BELOW
100 SMA$3.46-26.04%BELOW
150 SMA$3.88-34.00%BELOW
200 SMA$4.09-37.48%BELOW

Price Performance

1D-1.2%
1W+11.3%
1M+14.3%
3M-32.1%
6M-34.2%
YTD-44.8%
1Y-50.8%
3Y+6.0%
52-Week Trading Range7% from low
$2.56
52W Low$2.21
52W High$7.08

Technical Indicators

RSI (14)NEUTRAL
55.9
305070
VCP ScoreCOOL
2/10
Base depth: 75.4%

Risk Profile

Beta
1.92
52W Vol
88%
ATR
$0.14
Max DD (1Y)
-66%

Volume Analysis

Today
835.5K
50D Avg
1.44M
Vol Ratio
0.58x
Liquidity
MODERATE

Earnings Momentum

Q1'25-969%
$-0.17
Q2'25+26%
$-0.10
Q3'25+19%
$0.11
Q4'25+608%
$0.31
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+10.77%
3 Years:+7.76%
TTM:+16.99%

Compounded Profit Growth

10 Years:
5 Years:+0.00%
3 Years:+7.72%
TTM:+16.38%

Stock Price CAGR

10 Years:-12.52%
5 Years:-34.13%
3 Years:+5.99%
1 Year:-50.77%

Return on Equity

10Y Avg:-2.2%
5Y Avg:14.8%
3Y Avg:6.2%
Last Year:19.0%

Key Metrics

Market Cap$325M
Gross Margin
Net Margin10.1%
Piotroski F-Score3/9

Frequently Asked Questions

Is ORGO in an uptrend right now?

ORGO has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is ORGO overbought or oversold?

ORGO's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.

Is ORGO outperforming the market?

ORGO has a Relative Strength (RS) Rating of 9 out of 99. ORGO is currently lagging the broader market.

Where is ORGO in its 52-week range?

ORGO is trading at $2.56, which is 36% of its 52-week high ($7.08) and 7% above its 52-week low ($2.21).

How volatile is ORGO?

ORGO has a Beta of 1.92 and 52-week volatility of 88%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.